Head Diagnostics, a Dublin-based med-tech company, is developing innovative tech to aid in the diagnosis of Parkinson's and multiple sclerosis. Their Neuro platform will power a range of devices targeting diseases of the brain stem. The company is currently seeking regulatory approval from the FDA and EC to comply with American and European regulations.
CEO David van Zuydam envisions their technology being used globally by GPs and neurologists to make faster and more objective clinical decisions